Recent Media Coverage

Drug industry cash influences how doctors treat their patients.

The change could cut reimbursement for some of the best-selling drugs in America, in half, or more.

A new report provides a thorough analysis of the state of personalized oncology utilization across Europe.

From 2012 to 2018, the federal health care program spent $39.7 billion — adjusted for inflation and discounts — on inhalers to help plan beneficiaries combat asthma and chronic obstructive pulmonary disease, or COPD

Britain will pay individuals who suffer any severe side-effects from COVID-19 vaccines.

France will ensure free COVID-19 vaccinations for all in its social security system and has earmarked some 1.5 billion euros ($1.82 billion) of next year’s social security budget to cover the cost.

More than 60,000 people have now died in the UK after infection with coronavirus — one of the highest death rates in the world.

Former U.S. Presidents Barack Obama, George W. Bush and Bill Clinton said they were willing to be vaccinated against the novel coronavirus on television in order to ease any public skepticism over the safety of new vaccines.

UK NICE series of webinars discussing changes to process and methods for health technology evaluation.

The contracts are complicated and full of risks for drug companies. But there's also a risk to steering clear of the arrangements -- reduced or restricted access to a company's medication.

Gilead’s remdesivir is overpriced at $3,000, group says.

A participant in a COVID-19 vaccine trial has been sued for $13.5 million for defamation.